Guggenheim Adjusts Johnson & Johnson's Price Target to $160 From $167
MT NewswiresMay 1 21:54
Redburn Atlantic Adjusts Johnson & Johnson Price Target to $160 From $170
MT NewswiresApr 25 19:39
Neurocrine Biosciences Upgraded at Wells Fargo on Pipeline
Seeking AlphaApr 24 23:59
Johnson & Johnson Analyst Ratings
BenzingaApr 18 23:34
Johnson & Johnson Analyst Ratings
BenzingaApr 18 01:10
Cantor Fitzgerald: Reiterated the Johnson & Johnson (JNJ.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of $215.00.
Zhitong FinanceApr 17 21:30
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
BenzingaApr 17 21:28
Johnson & Johnson Analyst Ratings
BenzingaApr 17 18:32
Cantor Fitzgerald: Reiterated the Johnson & Johnson (JNJ.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of $215.00.
Zhitong FinanceApr 15 22:31
Johnson & Johnson Analyst Ratings
BenzingaApr 15 22:28
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
BenzingaApr 15 22:30
Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)
TipRanksApr 15 19:45
Morgan Stanley Trims Price Target on Johnson & Johnson to $168 From $169, Keeps Equalweight Rating
MT NewswiresApr 9 19:59
Johnson & Johnson Analyst Ratings
BenzingaMar 14 00:14
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
MT NewswiresFeb 28 23:50
Johnson & Johnson Analyst Ratings
BenzingaFeb 28 23:20
Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)
TipRanksFeb 21 16:20
Johnson & Johnson Analyst Ratings
BenzingaFeb 21 01:34
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
BenzingaFeb 6 22:52
Johnson & Johnson Analyst Ratings
BenzingaFeb 6 22:51
No Data
No Data